1. Home
  2. CTRM vs BOLT Comparison

CTRM vs BOLT Comparison

Compare CTRM & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRM
  • BOLT
  • Stock Information
  • Founded
  • CTRM 2016
  • BOLT 2015
  • Country
  • CTRM Cyprus
  • BOLT United States
  • Employees
  • CTRM N/A
  • BOLT N/A
  • Industry
  • CTRM Marine Transportation
  • BOLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRM Consumer Discretionary
  • BOLT Health Care
  • Exchange
  • CTRM Nasdaq
  • BOLT Nasdaq
  • Market Cap
  • CTRM 25.0M
  • BOLT 22.6M
  • IPO Year
  • CTRM N/A
  • BOLT 2021
  • Fundamental
  • Price
  • CTRM $2.38
  • BOLT $0.40
  • Analyst Decision
  • CTRM
  • BOLT Hold
  • Analyst Count
  • CTRM 0
  • BOLT 5
  • Target Price
  • CTRM N/A
  • BOLT $1.25
  • AVG Volume (30 Days)
  • CTRM 50.0K
  • BOLT 108.2K
  • Earning Date
  • CTRM 03-18-2025
  • BOLT 03-24-2025
  • Dividend Yield
  • CTRM N/A
  • BOLT N/A
  • EPS Growth
  • CTRM N/A
  • BOLT N/A
  • EPS
  • CTRM 2.39
  • BOLT N/A
  • Revenue
  • CTRM $76,443,340.00
  • BOLT $9,779,000.00
  • Revenue This Year
  • CTRM N/A
  • BOLT $9.87
  • Revenue Next Year
  • CTRM N/A
  • BOLT N/A
  • P/E Ratio
  • CTRM $1.02
  • BOLT N/A
  • Revenue Growth
  • CTRM N/A
  • BOLT 35.86
  • 52 Week Low
  • CTRM $2.33
  • BOLT $0.40
  • 52 Week High
  • CTRM $5.49
  • BOLT $1.56
  • Technical
  • Relative Strength Index (RSI)
  • CTRM 40.22
  • BOLT 35.84
  • Support Level
  • CTRM $2.37
  • BOLT $0.42
  • Resistance Level
  • CTRM $2.84
  • BOLT $0.47
  • Average True Range (ATR)
  • CTRM 0.15
  • BOLT 0.03
  • MACD
  • CTRM 0.00
  • BOLT -0.00
  • Stochastic Oscillator
  • CTRM 15.69
  • BOLT 18.57

About CTRM Castor Maritime Inc.

Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: